Literature DB >> 17174300

Subchronic nicotine exposure in adolescence induces long-term effects on hippocampal and striatal cannabinoid-CB1 and mu-opioid receptors in rats.

Eva M Marco1, Oleg Granstrem, Enrique Moreno, Ricardo Llorente, Walter Adriani, Giovanni Laviola, Maria-Paz Viveros.   

Abstract

There is evidence for the existence of functional interactions between nicotine and cannabinoids and opioid compounds in adult experimental animals. However, there is scarce information about these relationships in young animals. In the present study we evaluated short and long-term effects of a subchronic nicotine treatment [0.4 mg/kg daily i.p. injections from postnatal day (PND) 34 to PND 43], upon hippocampal and striatal cannabinoid-CB(1) and mu-opioid receptors in Wistar rats of both genders. Rats were sacrificed 2 h after the last nicotine injection (short-term effects, PND 43) or one month later (long-term effects, PND 75). Hippocampal and striatal cannabinoid CB(1) and mu-opioid receptors were quantified by Western blotting. The subchronic nicotine treatment induced a region-dependent long-lasting effect in cannabinoid CB(1) receptor: a significant increase in hippocampal cannabinoid CB(1) receptors and a significant decrease in striatal cannabinoid CB(1) receptors, with these effects being similar in males and females. With respect to mu-opioid receptors, subchronic nicotine induced a significant down-regulation in hippocampal and striatal mu-opioid receptors in the long-term, and within the striatum the effects were more marked in adult males than in females. The present results indicate that juvenile nicotine taking may have implications for the endocannabinoid and endogenous opioid function and for the behaviors served by those systems, this includes possible modification of the response of adults to different psychotropic drugs, i.e. cannabis and morphine/heroin when taken later in life.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17174300     DOI: 10.1016/j.ejphar.2006.11.013

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  25 in total

Review 1.  Endocannabinoid signalling in reward and addiction.

Authors:  Loren H Parsons; Yasmin L Hurd
Journal:  Nat Rev Neurosci       Date:  2015-09-16       Impact factor: 34.870

Review 2.  Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

Authors:  Antonia Serrano; Loren H Parsons
Journal:  Pharmacol Ther       Date:  2011-07-18       Impact factor: 12.310

3.  Operant self-administration of alcohol and nicotine in a preclinical model of co-abuse.

Authors:  A D Lê; Douglas Funk; Steven Lo; Kathleen Coen
Journal:  Psychopharmacology (Berl)       Date:  2014-04-03       Impact factor: 4.530

4.  Tobacco Smoking and Brain Endogenous Opioid Release: More Than Nicotine Alone.

Authors:  Edward F Domino; Mika Hirasawa-Fujita
Journal:  Nicotine Tob Res       Date:  2019-05-21       Impact factor: 4.244

5.  Reduced Brain Cannabinoid Receptor Availability in Schizophrenia.

Authors:  Mohini Ranganathan; Jose Cortes-Briones; Rajiv Radhakrishnan; Halle Thurnauer; Beata Planeta; Patrick Skosnik; Hong Gao; David Labaree; Alexander Neumeister; Brian Pittman; Toral Surti; Yiyun Huang; Richard E Carson; Deepak Cyril D'Souza
Journal:  Biol Psychiatry       Date:  2015-08-29       Impact factor: 13.382

Review 6.  Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives.

Authors:  Maria Scherma; Anna Lisa Muntoni; Miriam Melis; Liana Fattore; Paola Fadda; Walter Fratta; Marco Pistis
Journal:  Psychopharmacology (Berl)       Date:  2016-01-04       Impact factor: 4.530

Review 7.  Framework for sex differences in adolescent neurobiology: a focus on cannabinoids.

Authors:  Maria-Paz Viveros; Eva M Marco; Meritxell López-Gallardo; Luis Miguel Garcia-Segura; Edward J Wagner
Journal:  Neurosci Biobehav Rev       Date:  2010-09-30       Impact factor: 8.989

Review 8.  The effects of abused drugs on adolescent development of corticolimbic circuitry and behavior.

Authors:  J M Gulley; J M Juraska
Journal:  Neuroscience       Date:  2013-05-24       Impact factor: 3.590

9.  Sex differences in adult cognitive deficits after adolescent nicotine exposure in rats.

Authors:  Laura R G Pickens; James D Rowan; Rick A Bevins; Stephen B Fountain
Journal:  Neurotoxicol Teratol       Date:  2013-05-12       Impact factor: 3.763

Review 10.  Endogenous opioid system: a promising target for future smoking cessation medications.

Authors:  Haval Norman; Manoranjan S D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2017-03-11       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.